No title
Cancer patients often show varying response when given the same treatment for the same cancer type. This is especially true for cancer types with high molecular heterogeneity such as B-cell lymphomas which is a haematological cancer subtype. Because of this varying treatment response, research is moving towards enabling personalized medicine where a treatment is selected for each individual patien
